CA2469214A1 - Vecteur ameliore a base de polymere et de lipide - Google Patents

Vecteur ameliore a base de polymere et de lipide Download PDF

Info

Publication number
CA2469214A1
CA2469214A1 CA002469214A CA2469214A CA2469214A1 CA 2469214 A1 CA2469214 A1 CA 2469214A1 CA 002469214 A CA002469214 A CA 002469214A CA 2469214 A CA2469214 A CA 2469214A CA 2469214 A1 CA2469214 A1 CA 2469214A1
Authority
CA
Canada
Prior art keywords
polymer
delivery vehicle
lipid
nanoparticles
pcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002469214A
Other languages
English (en)
Inventor
Christine Allen
Murray Webb
Paul Tardi
Yumin Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELATOR TECHNOLOGIES Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2365806 external-priority patent/CA2365806A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002469214A priority Critical patent/CA2469214A1/fr
Priority claimed from PCT/CA2002/002009 external-priority patent/WO2003055469A1/fr
Publication of CA2469214A1 publication Critical patent/CA2469214A1/fr
Abandoned legal-status Critical Current

Links

Abstract

L'invention concerne des vecteurs comprenant des nanoparticules qui sont composées de: (a) un polymère hydrophobe biodégradable formant un noyau, et, (b) une couche extérieure amphiphile, entourant le noyau de polymère, contenant un lipide de stabilisation. Ces vecteurs sont adaptés à l'administration de principes actifs.
CA002469214A 2001-12-21 2002-12-23 Vecteur ameliore a base de polymere et de lipide Abandoned CA2469214A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002469214A CA2469214A1 (fr) 2001-12-21 2002-12-23 Vecteur ameliore a base de polymere et de lipide

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CA 2365806 CA2365806A1 (fr) 2001-12-21 2001-12-21 Vecteurs d'administration ameliores a base de polymere et de lipide
CA2,365,806 2001-12-21
US35763902P 2002-02-20 2002-02-20
US60/357,639 2002-02-20
US40198402P 2002-08-07 2002-08-07
US60/401,984 2002-08-07
PCT/CA2002/002009 WO2003055469A1 (fr) 2001-12-21 2002-12-23 Vecteur ameliore a base de polymere et de lipide
CA002469214A CA2469214A1 (fr) 2001-12-21 2002-12-23 Vecteur ameliore a base de polymere et de lipide

Publications (1)

Publication Number Publication Date
CA2469214A1 true CA2469214A1 (fr) 2003-07-10

Family

ID=32854341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002469214A Abandoned CA2469214A1 (fr) 2001-12-21 2002-12-23 Vecteur ameliore a base de polymere et de lipide

Country Status (1)

Country Link
CA (1) CA2469214A1 (fr)

Similar Documents

Publication Publication Date Title
US20030235619A1 (en) Polymer-lipid delivery vehicles
US20060177495A1 (en) Polymer-lipid delivery vehicles
Çağdaş et al. Liposomes as potential drug carrier systems for drug delivery
Zhao et al. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation
Jadhav et al. Novel vesicular system: an overview
Utreja et al. Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects
Da Silva et al. Nanotechnology-based drug delivery systems for treatment of tuberculosis—a review
US20060078624A1 (en) Microparticles and nanoparticles containing a lipopolymer
MXPA04012567A (es) Nanocapsulas lipidicas encubiertas, metodos para la preparacion de las mismas y uso de las mismas como un portador para principios activos.
Tiantian et al. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: Influence of formulation factors on the lymphatic targeting
WO2006102768A1 (fr) Excipient lipidique a base de solide colloidal destine a une utilisation pharmaceutique
WO2003103596A2 (fr) Preparations nanoparticulaires stabilisees de derives du camptotheca
US10792244B2 (en) Parenteral sustained-release delivery of carvedilol disperse systems
US20140105829A1 (en) Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same
EP1759699B1 (fr) Préparation de liposome contenant du camptothecin legérement soluble dans l'eau
Hani et al. A comprehensive review of current perspectives on novel drug Delivery systems and approaches for lung cancer management
WO2008094959A1 (fr) Composition pharmaceutique comprenant un dérivé de camptothécine
US8859001B2 (en) Fenoldopam formulations and pro-drug derivatives
CA2469214A1 (fr) Vecteur ameliore a base de polymere et de lipide
CN114126589A (zh) 脂质体阿霉素制剂、用于制备脂质体阿霉素制剂的方法和脂质体阿霉素制剂作为药物的用途
WO2020157729A1 (fr) Nanoparticule hybride lipide-polymère
WO2018124423A1 (fr) Composition de nanoparticules polymères pour l'administration d'adn plasmidique, et son procédé de préparation
CA2365806A1 (fr) Vecteurs d'administration ameliores a base de polymere et de lipide
Cavalcanti et al. Application of Pharmaceutical Nanotechnology in the Treatment of Cancer
TW200402312A (en) Improved polymer-lipid delivery vehicles

Legal Events

Date Code Title Description
FZDE Discontinued